Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

June 7, 2023
Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared HolzMerck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

Jared Holz, Mizuho healthcare sector specialist, joins ‘Fast Money’ to discuss Merck’s lawsuit against the federal government over Medicare drug pricing.

Share This

Latest Mizuho News

Prefer Novo short-term as a GLP-1 play, says Mizuho’s Jared Holz

Prefer Novo short-term as a GLP-1 play, says Mizuho’s Jared Holz

April 20, 2026
Iran war highlights risks in the chemical supply chain

Iran war highlights risks in the chemical supply chain

April 15, 2026
Wall Street jumps to near one-month highs after US-Iran ceasefire

Wall Street jumps to near one-month highs after US-Iran ceasefire

April 8, 2026

Mizuho news from around the globe

back-to-top-blue